Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Pickup

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
British Medical Journal (Clinical Research Ed.)|March 10, 1984
Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusionJ C Pickup, J J Bending, A C Collins, et al.
Diabetologia|June 1, 1979
Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 daysJ C Pickup, H Keen, J A Parsons, et al.
Lancet (London, England)|December 22, 1979
Subcutaneous desferrioxamine infusion for haemochromatosisD B Jefferys, J C Pickup, C M Haw, et al.
Diabetes Care|January 1, 1985
Rarity of a marked "dawn phenomenon" in diabetic subjects treated by continuous subcutaneous insulin infusionJ J Bending, J C Pickup, A C Collins, et al.
The British Journal of Ophthalmology|May 1, 1981
Reversal of diabetic retinopathy by continuous subcutaneous insulin infusion: a case reportM C White, E M Kohner, J C Pickup, et al.
Life Sciences|September 13, 2000
Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetesJ C Pickup, G D Chusney, S M Thomas, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Newer insulin delivery systems: continuous subcutaneous insulin infusionJ C Pickup, H Keen, J A Parsons, et al.
Diabetologia|February 1, 1983
Subcutaneous aprotinin causes local hyperaemia. A possible mechanism by which aprotinin improves control in some diabetic patientsG Williams, J C Pickup, S Bowcock, et al.
British Medical Journal|January 28, 1978
Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemiaJ C Pickup, H Keen, J A Parsons, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1979
Technology of pre-programmable insulin delivery systems: continuous subcutaneous insulin infusionJ C Pickup, H Keen, J A Parsons, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
British Medical Journal (Clinical Research Ed.)|March 10, 1984
Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusionJ C Pickup, J J Bending, A C Collins, et al.
Diabetologia|June 1, 1979
Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 daysJ C Pickup, H Keen, J A Parsons, et al.
Lancet (London, England)|December 22, 1979
Subcutaneous desferrioxamine infusion for haemochromatosisD B Jefferys, J C Pickup, C M Haw, et al.
Diabetes Care|January 1, 1985
Rarity of a marked "dawn phenomenon" in diabetic subjects treated by continuous subcutaneous insulin infusionJ J Bending, J C Pickup, A C Collins, et al.
The British Journal of Ophthalmology|May 1, 1981
Reversal of diabetic retinopathy by continuous subcutaneous insulin infusion: a case reportM C White, E M Kohner, J C Pickup, et al.
Life Sciences|September 13, 2000
Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetesJ C Pickup, G D Chusney, S M Thomas, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Newer insulin delivery systems: continuous subcutaneous insulin infusionJ C Pickup, H Keen, J A Parsons, et al.
Diabetologia|February 1, 1983
Subcutaneous aprotinin causes local hyperaemia. A possible mechanism by which aprotinin improves control in some diabetic patientsG Williams, J C Pickup, S Bowcock, et al.
British Medical Journal|January 28, 1978
Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemiaJ C Pickup, H Keen, J A Parsons, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1979
Technology of pre-programmable insulin delivery systems: continuous subcutaneous insulin infusionJ C Pickup, H Keen, J A Parsons, et al.
Pageof 13